Incidence of gastric side effects in controlled trials with unbranded aspirin and with various long-acting aspirin preparations.

Billings, R., Burry, H. C., Grahame, R., and Berry, D. J. (1975). A double blind crossover trial of prenazone and aspirin in the management of rheumatoid arthritis. Rheumatology and Rehabilitation, 14, 61-66. Dippy, J., Pritchard, M. H., and Lloyd, K. N. (1976). Aspirin in rheumatoid arthritis: a comparison of microencapsulated and enteric coated. Rheumatology and Rehabilitation, 15, 77-80. Fosdick, W. M., and Shepard, W. L. (1969). Enteric-coated microspherules. A clinical appraisal of two forms of aspirin. Journal of Clinical Pharmacology, 9, 126-129. Hill, H. F. H., Hill, A. G. S., Mowat, A. G., Ansell, B. M., Mathews, J. A., Seifert, M. H., Gumpel, J. M., and Christie, G. A. (1974). Naproxen, A new non-hormonal antiinflammatory agents. Annals of the Rheumatic Diseases, 33, 12-000. Huskisson, E. C., and Scott, J. (1978). Sulindac. Trials of a new anti-inflammatory drug. Annals of the Rheumatic Diseases, 37, 89-92. Sperryn, P. N., Hamilton, E. B. D., and Parsons, V. (1973). Double blind comparison of aspirin and benorylate in rheumatoid arthritis. Annals of the Rheumatic Disease, 32, 157-161.